Latest

psychopharmacology

·December 10, 2025·7 min read

Anti-Inflammatory Treatments Show Promise for Depression

A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who also have chronic, low-grade inflammation. By reviewing randomized controlled trials that specifically enrolled individuals with elevated inflammatory markers, researchers found that anti-inflammatory treatments significantly reduced both overall depressive symptoms and anhedonia.

Featured Neuroscience Psychology

·November 28, 2025·7 min read

CBD Can Reduce Aggression in Dogs

A massive multi-year analysis of tens of thousands of dogs reveals that CBD use is becoming increasingly common among aging companion animals. While dogs given CBD initially showed higher aggression, their aggression decreased below average levels with long-term use.

This shows the outline of a head in psychedelic colors.

Featured Neuroscience Psychology

·November 24, 2025·4 min read

Psychedelic ‘Ego Death’ Tied to a Collapse in Alpha Brain Waves

A new study using DMT as a scientific tool reveals how psychedelics alter the brain’s alpha-wave dynamics and weaken our sense of self. The researchers found that DMT pushes the brain away from its usual “critical” balance between chaos and order, a state believed to be essential for coherent self-awareness over time.

Featured Neuroscience Psychology

·November 6, 2025·6 min read

New Drug Exposes Hidden Subtypes of Psychosis

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years. Patients with strong negative symptoms responded best to the xanomeline–trospium combination, showing notable improvements in social behavior and mood.

Featured Neuroscience Psychology

·November 5, 2025·6 min read

Antibiotic Doxycycline May Cut Schizophrenia Risk

A large population-based study suggests that doxycycline, a common antibiotic, may reduce the risk of schizophrenia when prescribed to adolescents receiving mental health care. Researchers analyzed data from more than 56,000 young patients and found that those who took doxycycline had a 30–35% lower chance of developing schizophrenia later in life.

Featured Neuroscience Psychology

·October 30, 2025·6 min read

Common Antidepressant Eases Core Symptoms Within Two Weeks

A new analysis of the PANDA clinical trial reveals that sertraline, one of the most prescribed antidepressants, improves key emotional symptoms of depression—such as sadness, self-loathing, and suicidal thoughts—within just two weeks of treatment. Using network analysis to assess individual symptoms, researchers found that the drug also eased anxiety early on, while somatic effects like fatigue and low libido appeared but later stabilized.

Featured Neuroscience Psychology

·October 27, 2025·4 min read

Psychedelics May Rewire Memory Circuits Key to Mental Health

New research suggests that psychedelic drugs may work by strengthening specific brain connections linked to memory and cognition. Scientists found that under psychedelic exposure, neurons in the claustrum—a region dense with psychedelic-sensitive receptors—intensified their communication with the anterior cingulate cortex, a region involved in mood and psychiatric disorders.

Featured Neuroscience Psychology

·October 22, 2025·8 min read

Ketamine Fails to Outperform Placebo in Major Depression Trial

A large randomized and blinded clinical trial has found no additional benefit of repeated ketamine infusions over standard inpatient care for treating major depression. The study compared ketamine with a psychoactive placebo and found no meaningful differences in objective or self-reported depression scores, cognition, or quality of life.

This shows a woman, hearts, a brain, and brain waves.

Featured Neuroscience Psychology

·October 13, 2025·6 min read

EEG Test May Reveal Who Loses Libido on Antidepressants

A new study reveals that serotonin levels in the brain, measured using a simple EEG-based test, can predict who will experience sexual side effects from SSRI antidepressants. Researchers found that people with higher serotonin activity before treatment were significantly more likely to have difficulty reaching orgasm during antidepressant use.

Featured Neurology Neuroscience Pain Psychology

·October 2, 2025·6 min read

Psilocybin Rewire Brain Circuits Tied to Pain and Mood

New research shows that psilocybin, the active compound in psychedelic mushrooms, can reduce both chronic pain and pain-related depression by modulating brain circuits rather than acting at the site of injury. In mouse studies, a single dose provided pain relief and mood benefits lasting nearly two weeks by targeting the anterior cingulate cortex.

This shows a mom and child with a swirly background.

Featured Neuroscience Psychology

·September 30, 2025·7 min read

Psilocybin Worsens Postpartum Depression Symptoms

New research shows psilocybin, often studied as a treatment for mental health disorders, may worsen symptoms of postpartum depression in mice. Mothers given the drug showed more anxiety, avoidance of their pups, and lasting depressive-like behaviors.

Featured Neurology Neuroscience

·September 17, 2025·4 min read

Psychedelics Show Promise for Healing Concussions and Brain Injuries

Traumatic brain injuries, including concussions, affect nearly 69 million people worldwide each year, yet treatments remain scarce. A new review highlights the potential of psychedelics such as psilocybin and 5-MeO-DMT to reduce harmful inflammation and enhance neuroplasticity after brain injury.

1 2 3 … 40

psychopharmacology

Anti-Inflammatory Treatments Show Promise for Depression

CBD Can Reduce Aggression in Dogs

Psychedelic ‘Ego Death’ Tied to a Collapse in Alpha Brain Waves

New Drug Exposes Hidden Subtypes of Psychosis

Antibiotic Doxycycline May Cut Schizophrenia Risk

Common Antidepressant Eases Core Symptoms Within Two Weeks

Psychedelics May Rewire Memory Circuits Key to Mental Health

Ketamine Fails to Outperform Placebo in Major Depression Trial

EEG Test May Reveal Who Loses Libido on Antidepressants

Psilocybin Rewire Brain Circuits Tied to Pain and Mood

Psilocybin Worsens Postpartum Depression Symptoms

Psychedelics Show Promise for Healing Concussions and Brain Injuries

Brain Conductors Find Precise Connection to Target Cells via Protein Handshake

Multilingualism Calculator Reveals True Language Strengths

Brain Blends Fast and Slow Signals to Shape Human Thought

Immune Signal Ratio May Predict Progressive Multiple Sclerosis

Subscribe